Blog
RETATRUTIDE INJECTION
Retatrutide is an investigational once-weekly subcutaneous injection being developed by Eli Lilly for the treatment of obesity and type 2 diabetes. As of early 2026, it is in Phase 3 clinical trials and has not yet received regulatory approval from the FDA (US) or MHRA (UK).
Key Mechanisms and Efficacy
- GLP-1 (Glucagon-like peptide-1): Reduces appetite and slows digestion to make you feel full.
- GIP (Glucose-dependent insulinotropic polypeptide): Improves insulin response and fat metabolism.
- Glucagon (GCG): Increases energy expenditure and promotes the breakdown of stored fat.
Side Effects and Safety
- Gastrointestinal issues: Nausea, vomiting, diarrhea, and constipation are the most common.
- Heart Rate: Some participants experienced a dose-dependent increase in resting heart rate, which typically peaked at 24 weeks and then declined.
- Skin Sensitivity: About 7% of trial participants reported tingling or increased skin sensitivity (hyperesthesia).
- Serious Risks: Though rare, potential risks include pancreatitis and gallbladder disease.
Availability and Regulation
- Approval Timeline: Regulatory approval is not expected before late 2026 or 2027, following the conclusion of Phase 3 trials in mid-2026.
- Illegal Sources: Experts strongly warn against purchasing "retatrutide" from unregulated online sources or as "research peptides," as these products are illegal, potentially counterfeit, and may contain toxic ingredients.
- Legal Access: Currently, the only safe way to access retatrutide is by participating in a supervised clinical trial.
If you're overweight or you have obesity, losing 5% to 15% of your body weight can improve your heart health and lower your risk of type 2 diabetes. But losing weight can be hard to do. If diet and exercise haven't helped you reach a healthy weight and stay there, prescription weight loss drugs might help.
The FDA has already approved a group of weight loss drugs called GLP-1 receptor agonists. Medicines like liraglutide (Saxenda), semaglutide (Ozempic, Wegovy), and tirzepatide (Mounjaro, Zepbound) act like the hormone glucagon-like peptide in your body. They slow digestion and make you feel less hungry to help you lose more weight. These drugs also lower blood sugar levels to treat type 2 diabetes.
One form of semaglutide, Wegovy, is for adults with overweight or obesity who have at least one weight-related condition or cardiovascular disease. It now also comes as a daily pill to help you lose extra body weight, maintain long-term weight loss, and lower your risk for serious cardiovascular problems. You'll likely take the pill along with a lower calorie diet while increasing your physical activity.
Retatrutide
£90.00 – £215.00Price range: £90.00 through £215.00Cras consectetur
People taking the pills lost almost as much weight as those taking the injectable version of the drug. That’s according to a small clinical trial run by Novo Nordisk, so real-life results may vary.
Following the success of GLP-1 agonists, a new generation of weight loss drugs is coming down the research pipeline. Some are pills, which may be easier to take than the current injected drugs. Some work in different ways from the GLP-1 drugs.
A few weight loss drugs are in phase III trials. Phase III is the last phase of research before a drug company can ask the FDA for approval to market the medicine. Before a drug gets to phase III, it must go through a small phase I trial (20 to 100 people) to see if it's safe and what the recommended dosages might be. Then it goes through a slightly larger phase II study (100 to 300 people) to see how well it works. Researchers will also track any reported side effects.
Phase III studies can last for a few years. During this time, researchers will still be looking at how well the drug works, as well as following up on any bad reactions that people taking part might have. Some of the drugs listed below may come to market in the next few months or years. Others won't get approved at all. Coming up behind them are many more new weight loss drugs that are in different stages of development.
Related Posts
MOUNJARO KWIKPEN
-
Posted by
admin
- 0 comments